The effect of edelfosine on CTP:cholinephosphate cytidylyltransferase activity in leukemic cell lines.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  1996-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0145-2126(96)00070-7PMID 9009253
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary structure and expression of a human CTP:phosphocholine cytidylyltransferase.

  1994cited by this paper
• Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer.

  1993cited by this paper
• Hexadecylphosphocholine inhibits translocation of CTP:choline-phosphate cytidylyltransferase in Madin-Darby canine kidney cells.

  1992cited by this paper
• Choline-phosphate cytidylyltransferase.

  1992cited by this paper
• Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.

  1992cited by this paper
• Regulation of CTP:phosphocholine cytidylyltransferase activity and subcellular location by phosphorylation in Chinese hamster ovary cells. The effect of phospholipase C treatment.

  1991cited by this paper
• Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues.

  1990cited by this paper
• Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.

  1990cited by this paper
• Effects of thioether phospholipid BM 41.440 on protein kinase C and phorbol ester-induced differentiation of human leukemia HL60 and KG-1 cells.

  1988cited by this paper
• Antileukemic agent alkyllysophospholipid regulates phosphorylation of distinct proteins in HL60 and K562 cells and differentiation of HL60 cells promoted by phorbol ester.

  1987cited by this paper
• Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines.

  1985cited by this paper
• Cytotoxicity of platelet activating factor and related alkyl-phospholipid analogs in human leukemia cells, polymorphonuclear neutrophils, and skin fibroblasts.

  1984cited by this paper
• Membrane-bound CTP:phosphocholine cytidylyltransferase regulates the rate of phosphatidylcholine synthesis in HeLa cells treated with unsaturated fatty acids.

  1984cited by this paper
• Fatty acids promote translocation of CTP:phosphocholine cytidylyltransferase to the endoplasmic reticulum and stimulate rat hepatic phosphatidylcholine synthesis.

  1983cited by this paper
• Regulation of rat liver cytosolic CTP: phosphocholine cytidylyltransferase by phosphorylation and dephosphorylation.

  1982cited by this paper
• The effects of alkyl-lysophospholipids on leukemic cell lines. I. Differential action on two human leukemic cell lines, HL60 and K562

  1981cited by this paper
• The effects of alkyl-lysophospholipids on leukemic cell lines. I. Differential action on two human leukemic cell lines, HL60 and K562.

  1981cited by this paper
• Augmenting agents in cancer therapy

  1981cited by this paper
• Regulation of phosphatidylcholine biosynthesis in cultured chick embryonic muscle treated with phospholipase C.

  1980cited by this paper
• Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids.

  1979cited by this paper
• Selective destruction of human leukemic cells by alkyl-lysophospholipids.

  1978cited by this paper
• Assay of proteins in the presence of interfering materials.

  1976cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Impact of targeting the platelet-activating factor and its receptor in cancer treatment

  2025cites this paper
• Uncovering the Potential of Lipid Drugs: A Focus on Transient Membrane Microdomain-Targeted Lipid Therapeutics.

  2022cites this paper
• Molecular Docking Reveals the Binding Modes of Anticancer Alkylphospholipids and Lysophosphatidylcholine within the Catalytic Domain of Cytidine Triphosphate: Phosphocholine Cytidyltransferase

  2020cites this paper
• In vitro activities of adamantylidene-substituted alkylphosphocholine TCAN26 against Trypanosoma cruzi: Antiproliferative and Ultrastructural effects.

  2019cites this paper
• The New Age for Discovering New Selective Antitumor Agents : Antineoplastic Phospholipids

  2017cites this paper
• Anticancer mechanisms and clinical application of alkylphospholipids.

  2013cites this paper
• The Arabidopsis DREB2 genetic pathway is constitutively repressed by basal phosphoinositide-dependent phospholipase C coupled to diacylglycerol kinase

  2013cites this paper
• Effects of miltefosine on the proliferation, ultrastructure, and phospholipid composition of Angomonas deanei, a trypanosomatid protozoan that harbors a symbiotic bacterium.

  2012cites this paper
• PG12, a Phospholipid Analog with Potent Antimalarial Activity, Inhibits Plasmodium falciparum CTP:Phosphocholine Cytidylyltransferase Activity*

  2011cites this paper
• Antiprotozoal/Antiparasitic Agents

  2010cites this paper
• Different cell death pathways induced by drugs in Trypanosoma cruzi: an ultrastructural study.

  2009cites this paper
• Testing the hypothesis that amphiphilic antineoplastic lipid analogues act through reduction of membrane curvature elastic stress

  2008cites this paper
• Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects.

  2008cites this paper
• Miltefosine Affects Lipid Metabolism in Leishmania donovani Promastigotes

  2007cites this paper
• Mechanisms of action of lysophospholipid analogues against trypanosomatid parasites.

  2006cites this paper
• Characterisation of neuropathy target esterase in mammalian cells.

  2005cites this paper
• Antiprotozoal lysophospholipid analogues: a comparison of their activity against trypanosomatid parasites and tumor cells.

  2004cites this paper
• Chemotherapy of Chagas disease.

  2002cites this paper
• Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH(3) (edelfosine), a proapoptotic agent in tumor cells.

  2002cites this paper
• Regulation of mammalian cell membrane biosynthesis.

  2001cites this paper
• Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: potentiation of in vitro activity by the sterol biosynthesis inhibitor ketoconazole.

  2001cites this paper
• Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruzi.

  2000cites this paper
• Mechanisms of action of phospholipid analogs as anticancer compounds.

  1999cites this paper
• The inhibition of cell signaling pathways by antitumor ether lipids.

  1998cites this paper
• Induction of Ceramide-mediated Apoptosis by the Anticancer Phospholipid Analog, Hexadecylphosphocholine*

  1998cites this paper
• Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.

  1998cites this paper